Introduction {#S0001}
============

Chronic skin lesions due to ageing represent a problem increasingly felt by the National Health Systems which, in both the European countries and in the USA, come to allocate resources up to 2--5% of the overall healthcare expenditure.[@CIT0001] The set of interventions, including the prevention of chronic skin lesions and all those activities of assistance and therapy to promote their healing, is defined as wound care.

Skin wound healing is a complex process, dependent upon the cell types and the chemical mediators interacting in a highly sophisticated time sequence. It is a dynamic process triggered as a response to tissue injury, aims at repairing the matrix and the cell damages, and at restoring the skin barrier integrity, proceeding through four overlapping phases: haemostasis, inflammation, proliferation and remodelling.[@CIT0002] The healing process starts with the haemostasis stage, consisting of the formation of blood clot that fills up the tissue discontinuity. This stage is connected with the formation of a temporary matrix, the secretion of cytokines and other growth factors that, by interacting with the extra cellular matrix (ECM) components, trigger the whole repairing process. The following inflammatory phase is initiated by neutrophils under the influence of macrophages, which clean the wound area from bacteria and debris and release proinflammatory cytokines and growth factors, in turn, responsible for recruitment and activation of fibroblasts and epithelial cells.[@CIT0003] The proliferative phase is characterized by the rebuilding of the damaged tissue, and by an increase in the number of cells in the wound site due to the migration and the proliferation of fibroblasts, endothelial cells and keratinocytes.[@CIT0004] During this phase fibroblasts, in the presence of the newly formed blood vessels, proliferate actively and synthesize the ECM components, which, besides their structural role, fulfil a signalling function regulating the dynamic, interactive sequence of biological events. The last phase, the remodelling, occurs when the wound surface is contracted, new epithelium develops and the final scar tissue is formed.

The skin wound healing has been well studied for decades and several plant extracts, and plant-derived products, have been developed with the goal of improving and enhancing the repairing process.[@CIT0005]--[@CIT0007] Among them, *Triticum vulgare* has been extensively used in traditional medicine thanks to its properties of accelerating tissue repair. In particular, an aqueous extract of *Triticum vulgare*, with bio-inductive properties, obtained from the whole-germinated plants according to a procedure already described by Sanguigno (2015) and patented (Riccio, 2012), was very helpful in accelerating the wound healing process acting through different mechanisms.[@CIT0008],[@CIT0009] It was demonstrated that the extract of *Triticum vulgare* was able to induce the proliferation of fibroblasts and of endothelial cells giving an acceleration to wound repair.[@CIT0010]--[@CIT0013] This was confirmed by studies on animal models where it was demonstrated that *Triticum vulgare* extract regenerated skin lesions.[@CIT0008] In particular, the active components of *Triticum vulgare* extract were isolated and the fraction responsible for the stimulation of tissue regeneration was identified.[@CIT0008] This fraction was obtained through ultrafiltration and contains oligosaccharides with an MW higher than 1000 Da. Further evidences indicated that the *Triticum* extract was also able to reduce the inflammatory reaction and to prevent damages due to the wound-related inflammation.[@CIT0014] Up to this moment, it has been shown that the *Triticum* extract had pro-healing activity acting on the proliferation phase of wound healing and in chronic inflammation.

The present work was aimed at demonstrating that the patented aqueous extract of *Triticum vulgare* (TVE), rich in oligosaccharides, exerted a significant wound healing activity regulating also the other important steps of the wound healing process. First of all, we confirmed the effect of TVE in wound healing, already reported in the literature,[@CIT0008] then we verified whether TVE was able to increase the synthesis of fibronectin, a key ECM component in the dermis, as well as the expression of Hyaluronan synthase 2 (HAS2), the most abundant HAS in fibroblasts.[@CIT0015] Then, we analysed the ability of TVE to enhance actin polymerization in fibroblasts. Actin fibres, the main constituents of the cell cytoskeleton, drive cell motility, adhesion and contraction during the wound healing signalling pathways.[@CIT0016] Finally, we studied the effect of TVE on the restoration of the epidermal barrier, by analysing the activity of the enzyme β- glucocerebrosidase, main responsible for the production of the ceramides that account for 30--40% of the stratum corneum lipids.

Materials and Methods {#S0002}
=====================

Plant Description {#S0002-S2001}
-----------------

*Triticum vulgare*, the binomial scientific name of a plant of the Graminaceae family, is the commonly known wheat plant. It is grown under controlled conditions in the Farmaceutici Damor laboratory, Naples, Italy; the voucher specimen is DF/237/2014, and it is deposited in the herbarium of the Medical Botany Chain of University of Salerno, Italy. The commercially available seeds were purchased from the "Consorzio Agrario Lombardo Veneto" (San Giorgio sul Panaro, Modena, Italy).

*Triticum vulgare* Extract Preparation {#S0002-S2002}
--------------------------------------

TVE is an aqueous extract of *Triticum vulgare*, obtained through a patented process (Riccio, 2012): it was prepared according to standard manufacturing protocol of germination under restricted conditions of temperature, light and humidity, extraction using water, sulfuric and chloride acid, and purification with membrane filter as described in Common Technical Document (CTD) and filed at Italian Medicines Agency (AIFA) by Farmaceutici Damor.[@CIT0009] The concentrations used for the experiments were 3% and 15% (v/v). These concentrations were verified for their safety on the cells performing a MTT assay.

Cell Cultures {#S0002-S2003}
-------------

Human Dermal Fibroblasts (HDF, Cell Applications Inc., San Diego, CA) derived from neonatal foreskin and immortalized human keratinocytes HaCaT (AddexBio Technologies, San Diego, CA) were maintained in DMEM supplemented with 10% of fetal bovine serum in a 95% air, 5% CO~2~ and humidified atmosphere at 37°C.

Scratch Assay {#S0002-S2004}
-------------

4.5 x 10^5^ cells were seeded in 6-well plates. 16 hrs later same areas of each well were displaced by scratching a line through the cell layer by a pipet tip. Floating cells were removed by PBS washing. Media containing 0.5% FBS with or without treatment was added and the cells incubated for 7 hrs, TGFβ 5ng/mL was used as positive control. To estimate the relative migration of the cells, we compared, for each conditions, the unclosed cell-free areas at time 0 and 7 hrs after treatments by using the software Image J.

Gene Expression Analysis {#S0002-S2005}
------------------------

1 x 10^5^ HDF were seeded in 6 well plates, incubated for 16 h and then treated for 6 hrs with TVE and the positive control for Fibronectin and HAS2 gene expression analyses. To analyse the expression level of β-glucocerebrosidase (GBA), 1.5 x 10^5^ HaCaT were seeded in 6-well plates and treated for 6 hrs with TVE and the positive control. At the end of the incubation time, total RNA was extracted with the GenElute Mammalian Total RNA Purification Kit (Sigma-Aldrich, Milano, Italy) and treated with DNAse I at 37°C for 30ʹ. Reverse transcription was performed using the RevertAid**™** First Strand cDNA Synthesis Kit (Thermo Fisher Scientific, Dallas, TX, USA). RT-PCR was performed with the Quantum RNA**™** kit (Ambion) containing primers to amplify 18S rRNA along with competimers that reduce the amplified 18S rRNA product within the range to be used as endogenous standard. Primers used are listed in [Table 1](#T0001){ref-type="table"}. The amplification reactions were performed using the Mastercycler**™** ProS (Eppendorf, Milano, Italy) with the following general scheme: 2ʹ at 94°C followed by 35 cycles of 94°C for 30s, 50°C for 30 s, and 72°C for 30 s, with a 10 mins final extension at 72°C. The PCR products were loaded on 1.5% agarose gel, and the amplification bands were visualized and quantified with the Geliance 200 Imaging system (Perkin Elmer, Woodbridge, Ontario, Canada). The amplification band corresponding to the analysed gene was normalized to the amplification band corresponding to the 18S and reported as percentage of untreated controls (fixed as 100%). RT-PCRs reactions were made in triplicate, and the average results were reported in the graph. The sequence of used primers was reported in [Table 1](#T0001){ref-type="table"}.Table 1List of Primers Used for Gene Expression ExperimentsName of GeneForwardReverse*Fibronectin (FN)*CAGGCTCAGCAAATGGTTAAGTCCCAGCAGCATGATC*Hyaluronan Synthase 2 (HAS2)*CTGTGAAAAGGCTAACCCTAATGCACTGAACACAC*β-glucocerebrosidase (GBA)*AGTTGCACAACTTCAGCGTCCAGGTACCAATGTAC

ELISA for Fibronectin Protein Measure {#S0002-S2006}
-------------------------------------

9 x 10^3^ HDF were seeded in 96-well plates and treated with TVE and the control for 72 hrs. After the treatments, the medium was removed and the cells were washed with PBS 1x, fixed in paraformaldehyde (PFA) 4% for 10ʹ, washed three times with PBS 1x, and permeabilized with 1% Triton X-100 in PBS for 30ʹ. The cells were then treated for 30ʹ with 0.5% Tween 20 and 5% BSA in PBS and incubated at 4°C with primary goat polyclonal antibody, raised against human fibronectin (C-20) (Santa Cruz Biotechnology, Dallas, TX, USA), diluted 1:500 in PBS 1x, containing 0.5% Tween 20 and 1% BSA. 16 hrs later, samples were washed 3 times with PBS + 0.5% Tween 20, incubated with anti-goat secondary antibody, labelled with Horse-Radish Peroxidase (HRP) (Santa Cruz Biotechnology) and diluted 1:1000 in PBS 1x, containing 0.5% Tween 20 and 1% BSA. One hour later, plates were washed 3 times with PBS 1x and the amount of fibronectin produced by the cells was measured by a colorimetric reaction, using a 0.5mg/mL solution of O-PhenylenDiamine (OPD) (Sigma-Aldrich) and 0.012% H~2~O~2~ in citrate buffer 50mM. The plate was incubated at RT until the yellow colour developed. The absorbance of each sample was measured at 490 nm by the Multiwell Plate Reader Victor3 (Perkin Elmer).

Immunofluorescence for Fibronectin {#S0002-S2007}
----------------------------------

1.5 x 10^5^ HDF were seeded on glass slides in 6-well plates and treated with TVE and the control for 72 hrs. After the treatments, the medium was removed and the cells were washed with PBS 1x, fixed in paraformaldehyde (PFA) 4% for 10ʹ, washed three times with PBS 1x, and permeabilized with 1% Triton X-100 in PBS for 30ʹ. The cells were then treated for 30ʹ with 0.5% Tween and 5% BSA in PBS and incubated overnight at 4°C with primary mouse monoclonal antibody, raised against human fibronectin (A-11) (Santa Cruz Biotechnology) diluted 1:200 in PBS 1x, containing 0.5% Tween and 1% BSA. After incubation, samples were washed 3 times with PBS + 0.5% Tween 20, incubated with anti-mouse secondary antibody, labelled with Alexa Fluo 488 (Thermo Scientific) and diluted 1:1000 in PBS 1x, containing 0.5% Tween 20 and 1% BSA in presence of DAPI 0.5ug/mL. One hour later, the slides were washed 3 times with PBS + 0.5% Tween 20 and the slides were mounted on coverslip using PBS with 50% of glycerol. The intensity of fluorescence was measured using ImageJ software and the data reported in the graph represented the ratio between the fluorescence intensity and the number of nuclei.

Actin Polymerization Assay {#S0002-S2008}
--------------------------

HDF were seeded at a density of 2 x 10^5^ in 24 well plates, incubated for 16 hrs and then treated with TVE or the control compounds for 30 mins. At the end they were washed with cold PBS 1X, fixed in formaldehyde 4% for 10ʹ at 4°C and permeabilized with 0.2% TritonX100 in PBS 1X for 30 min. The cells were then incubated for 1 hr in the dark with 0.4 mM Rhodamin-Phalloidin in PBS 1X, washed twice in PBS 1X and solubilized with 300 μL of methanol. The plate was read by the Multiwell-plate Reader, Victor 3 (Perkin Elmer), exciting the samples at 530nm and recording the fluorescence at 590nm. Each sample was run in triplicates and the experiments were repeated three times.

GBA Activity Assay {#S0002-S2009}
------------------

HaCaT were seeded at a density of 1 x10^5^ in 6-well plates and treated for 24 hrs with TVE or the positive control. After the treatments, the cells were collected and resuspended in lysis buffer (0.1 M citrate/0.2 M phosphate buffer, pH 5.2, 0.25% sodium taurocholate, 0.1% Triton X-100). The amount of total proteins in each sample was determined by Bradford assay and 25 μg of proteins were incubated with 6 mM of the fluorescent GBA substrate, 4-methylumbelliferyl β-D-glucopyranoside. After 2h, the reaction was stopped by the addition of 0.1M glycine/0.1M NaOH, pH 10.7, and the amount of fluorescent product was measured spectrophotometrically by excitation at 365 nm and emission at 448nm, using the Multiwell Plate Reader Victor3 (Perkin Elmer). Each sample was run in triplicate and the average of three independent experiments was reported.

Nile Red Assay {#S0002-S2010}
--------------

1 x 10^4^ HaCaT were seeded in 96-well plates and grown for 72 hrs. Then, the cells were treated with TVE or positive control for 24 hrs. The next day the intracellular lipid content was measured using Nile Red dye (AdipoRed Assay Reagent Lonza): the cells were carefully washed with PBS, and then stained with AdipoRed according to provider instruction. After 10 min, the fluorescence of the samples was measured using an excitation wavelength of 485 nm and an emission of 570 nm using Victor3 (PerkinElmer). The intracellular lipid content was related to cell density determined by crystal violet staining.

Statistical Analysis {#S0002-S2011}
--------------------

Experiments were performed at least three times and the data were expressed as the mean ± the standard deviation of the values obtained by three independent experiments. Statistical comparisons between controls and treated groups were performed according to *t*-test using the software GraphPad prism version 8. P values lower than 0.05 were considered statistically significant. The number of asterisks in the graphs indicate the level of significance (\*\*\* p value is between 0.0001 to 0.001; \*\*0.001 to 0.01; \*0.01 to 0.05).

Results {#S0003}
=======

Activity of TVE on Wound Repair {#S0003-S2001}
-------------------------------

To determine the right usage concentrations, we evaluated TVE cytotoxicity in HaCaT and HDF cells treated for 48 hrs with increasing amount of TVE (from 0.1 to 30% v/v) and cell viability was determined by MTT assay (data not shown). No significant cytotoxicity was recorded at all concentrations used.

In order to confirm the previous reported data[@CIT0008] on the effects of TVE on wound closure acceleration, HDF, grown in monolayer, were mechanically wounded and the closure of wound edges in the presence of 3% and 15% of TVE was evaluated by light microscopy. As positive control, due to its ability of wound repair, was used TGFβ 5ng/mL.[@CIT0017] As shown in [Figure 1](#F0001){ref-type="fig"}, the two concentrations of TVE accelerated the wound repair capacity of the cells, respectively, by 14% and 28%.Figure 1Effect of TVE on wound closure. HDF were mechanically scratched and then treated with TVE at indicate concentration and analysed after 7 hrs for the wound area measurement. The results, reported in panel **A**, are the averages of three independent experiments, expressed as percentages respect to the untreated cells, arbitrarily set as 100%. The error bars represent standard deviations and the asterisks indicate statistically significant values (\*\* p value is between 0.001 to 0.01). In panel **B** are reported representative pictures for each treatment.

Activity of TVE on the Synthesis of Dermis ECM Components {#S0003-S2002}
---------------------------------------------------------

To evaluate whether TVE was capable of modulating new fibronectin synthesis, HDF were treated with TVE at concentrations of 3% and 15%, and the gene expression and protein production of fibronectin were measured by RT-PCR and ELISA assay, respectively. As positive control was used TGFβ 5ng/mL, known for its ability to induce fibronectin synthesis.[@CIT0018] As shown in [Figure 2](#F0002){ref-type="fig"}, the two TVE concentrations significantly induced both the fibronectin gene expression and production at a similar level. Furthermore, we measured the quantity of fibronectin protein by immuno-fluorescence in way to visualize the protein in the extracellular matrix context. The immunofluorescence results, shown in [Figure 3](#F0003){ref-type="fig"}, clearly revealed that TVE, in a dose-dependent way, increased the production of fibronectin. Furthermore, fibronectin was shown to be correctly localized in the extracellular matrix.Figure 2Effect of TVE on fibronectin gene and protein synthesis. HDF were treated with TVE at the indicated concentrations and then gene expression and protein synthesis were analysed after 6 h and 72 h, respectively. The results are the averages of three independent experiments, expressed as percentages respect to the untreated control, arbitrarily set as 100%. The error bars represent standard deviations, and the asterisks indicate statistically significant values (\*\*\* p value is between 0.0001 to 0.001; \*\*0.001 to 0.01; \*0.01 to 0.05).Figure 3Effect of TVE on Fibronectin protein localization. HDF were treated with TVE at the indicated concentrations and after 72 h they were processed for immunofluorescence analysis. In the panel **A,** it was reported the fluorescence quantification corresponding to fibronectin production. The results are the averages of three independent experiments, expressed as percentages respect to the untreated control, arbitrarily set as 100%. The error bars represent standard deviations, and the asterisks indicate statistically significant values (\*\* p value is between 0.001 to 0.01; \*0.01 to 0.05). In the panel **B,** they were reported representative pictures for each treatment.

In addition to fibronectin, we measured hyaluronan synthase 2 (HAS2) gene expression level after treating HDF with TVE 3% and 15%. Analogously to the previous experiments, TGFβ 2.5 ng/mL was used as positive control.[@CIT0015] TVE at both the concentrations increased the expression of HAS2 by around 70% ([Figure 4](#F0004){ref-type="fig"}).Figure 4Effect of TVE on hyaluronan synthase 2 gene expression. HDF were treated with TVE 3% and 15% for 6 hrs, and then gene expression was analysed. The results are the averages of three independent experiments, expressed as percentages respect to the untreated control, arbitrarily set as 100%. The error bars represent standard deviations, and the asterisks indicate statistically significant values (\*\* p value is between 0.001 to 0.01; \*0.01 to 0.05).

Activity of TVE on Actin Polymerization in HDF {#S0003-S2003}
----------------------------------------------

To investigate on the activity of TVE on cell migration, we measured the amount of new polymerized actin in HDF after the treatment with 3% and 15% of TVE. As controls, 2 μg/mL of phosphatidic acid (PA) and 2 μM of cytochalasin B were used for their effect of increasing and blocking actin polymerization, respectively.[@CIT0019],[@CIT0020] TVE treatment, at both concentrations, increased the amount of polymerized actin by almost 250%, indicating a strong stimulatory effect on the formation of the pseudopods, responsible for cell movement and progression ([Figure 5](#F0005){ref-type="fig"}).Figure 5Effect of TVE on polymerization of actin. HDF were treated with TVE at 3% and 15% for 30 mins and then polymerized actin was measured in the cell lysates. The results are the averages of three independent experiments, expressed as percentages respect to the untreated control, arbitrarily set as 100%. The error bars represent standard deviations, and the asterisks indicate statistically significant values (\*\*\* p value is between 0.0001 to 0.001; \*\*0.001 to 0.01; \*0.01 to 0.05).

Effects of TVE on GBA Gene Expression and Activity in Keratinocytes {#S0003-S2004}
-------------------------------------------------------------------

To study the activity of TVE on the epidermal barrier formation, the expression and the activity of the enzyme GBA were measured in human keratinocytes (HaCaT), after the treatment with TVE at 3% and 15%. As shown in [Figure 6A](#F0006){ref-type="fig"} and [B](#F0006){ref-type="fig"}, TVE increased both GBA gene expression and protein activity at both the concentrations. The effect on the enzymatic activity was particularly evident, resulting in 136% and 107% increases. As positive controls in the assays, Retinoic acid 1uM and T0901317 10uM were used.[@CIT0021],[@CIT0022] Furthermore, we analysed if following the increase in expression and activity of GBA, the treatment of TVE induced also an increase in neutral lipid accumulation performing a semi-quantitative fluorescence assay with Nile Red (AdipoRed Lonza). As it is shown in [Figure 7](#F0007){ref-type="fig"} after the treatment with TVE 3% and 15% the epidermal lipid content increased by 40% and 60%, respectively, more than untreated cells. As positive control, T0901317 10uM was used.[@CIT0022]Figure 6Effect of TVE on GBA gene expression and activity. HaCaT cells were treated with TVE at 3% and 15% for 24 hrs, and then both gene expression and enzymatic activity were measured by RT-PCR and GBA activity assay, respectively. In the panel **A,** it was reported the gene expression analysis, and in the panel **B,** the enzymatic activity. The results are the averages of three independent experiments, expressed as percentages respect to the untreated control, arbitrarily set as 100%. The error bars represent standard deviations, and the asterisks indicate statistically significant values (\* p value is between 0.01 to 0.05).Figure 7Effect of TVE on epidermal lipid production. HaCaT cells were treated with TVE for 24 hrs and then stained with Nile Red. In the graph, there are reported the average results of three independent experiments, expressed as percentages respect to the untreated control, arbitrarily set as 100%. The error bars represent standard deviations, and the asterisks indicate statistically significant values(\*\*\* p value is between 0.0001 to 0.001; \*0.01 to 0.05).

Discussion {#S0004}
==========

In this study, we focused on understanding mechanisms of action of a patented hydrosoluble extract of *Triticum vulgare* (TVE) on its already identified pro-healing activity in skin cells. We demonstrated that it induced the synthesis of fibronectin and hyaluronan synthase 2, enhanced the polymerization of actin in dermal fibroblasts and stimulated new lipid production in epidermal keratinocytes. These four functions are of key importance for the skin healing process since they are related to the formation of new tissue following the first phase of wound healing. In particular, it was already demonstrated that the *Triticum vulgare* aqueous extract reduced the expression levels of inflammatory mediators, such as IL-6, TNFα, prostaglandin E2, nitric oxide. Then, it was proved that the extract of *Triticum* was able to increase cell proliferation inducing an acceleration of wound repair. Here we demonstrated that the extract was effective in regulating wound repair also during the remodelling phase. In particular, fibronectin is a key factor during the healing process, as it is involved in cell differentiation and migration, and serves as a binding site for a number of growth factors.[@CIT0023] Moreover, it coordinates the deposition of new ECM proteins, such as collagens and thrombospondin I, and promotes cellular adhesion and communication.[@CIT0024],[@CIT0025]

On the other hand, HAS2 is responsible for the synthesis of HA, which in turn plays an essential role in the formation of new matrix and in the modulation of the wound healing proliferative phase. HA has been extensively linked to tissue hydration, and, as signalling molecule, it interacts with cell surface receptors, stimulating cell migration, proliferation and differentiation.[@CIT0026],[@CIT0027] Moreover, it is able to swell and create a woven structure, that enables the coming cells to penetrate the wound area.[@CIT0028] By inducing both the factors simultaneously, TVE may favour the formation of the right scaffold factors, required for the migration of fibroblast and for the deposition of new ECM.

Furthermore, we demonstrated that TVE was able to stimulate the polymerization of actin, the motor of cell contractility and movement. An increase of actin polymerization has been linked to an increase in cell migration on wound edge and an improvement of wound contraction.[@CIT0016] By increasing the level of polymerized actin in fibroblasts, TVE could regulate the proliferative and remodelling phases of wound healing, accelerating the ability of fibroblasts to repair the damage. Another key event in wound healing is the skin barrier restoration. In healthy skin, a perturbation of the skin barrier initiates a sequence of events that rapidly results in the return of lipids to the stratum corneum and the restoration of its barrier function. Following a disruption of the barrier, the increase in cholesterol and fatty acid synthesis in the epidermis occurs within few hours, whereas the increase in sphingolipid synthesis requires longer times.[@CIT0029] It was demonstrated that the inhibition of the epidermal lipid synthesis delayed barrier function restoration.[@CIT0030] By promoting the activity of β-glucocerebrosidase and the synthesis of new ceramides in keratinocytes, TVE could thus improve the epidermal barrier functions during wound repair.

Conclusion {#S0005}
==========

In conclusion, this work provides additional clues about the use of a peculiar *Triticum vulgare* aqueous extract as active ingredient in wound care and dermatology, more specifically addressed to regenerate damaged tissues.
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